Maguate, Gresna .
HRN: 26-05-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/26/2024
11/01/2024
IV
2.25gm
Q6
Septicemia; Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes